849322-40-3

Basic information

• Product Name: 3H-Pyrrolo[3,4-c]pyridin-3-one, 1,2-dihydro-1-hydroxy-1-phenyl-
• CAS NO: 849322-40-3
• Molecular Formula: C13H10N2O2
• Molecular Weight: 226.235
• Mol File: 849322-40-3.mol

Chemical Properties

• CAS DataBase Reference: 3H-Pyrrolo[3,4-c]pyridin-3-one, 1,2-dihydro-1-hydroxy-1-phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 3H-Pyrrolo[3,4-c]pyridin-3-one, 1,2-dihydro-1-hydroxy-1-phenyl-(849322-40-3)
• EPA Substance Registry System: 3H-Pyrrolo[3,4-c]pyridin-3-one, 1,2-dihydro-1-hydroxy-1-phenyl-(849322-40-3)

Safety Data

• Hazardous Substances Data: 849322-40-3(Hazardous Substances Data)

Upstream product

• 77924-01-7 N,N-diisopropylnicotinamide 
• 74975-25-0 4-benzoylpyridine-3-carboxylic acid 
• 611-74-5 N,N-dimethylbenzamide 
• 104084-46-0 4-[hydroxy(phenyl)methyl]-N,N-diisopropylnicotinamide 
• 849322-39-0 1-phenyl-1,3-dihydrofuro[3,4-c]pyridin-3-one 
• 88329-46-8 N,N-Diisopropyl-4-benzoyl-3-pyridinecarboxamide 
• 104867-64-3 1-Chloro-1-phenyl-1H-furo[3,4-c]pyridin-3-one 
• 4664-01-1 3,4-pyridinedicarboximide 
• 591-51-5 phenyllithium 

Downstream Products

• 1346510-94-8 (RS)-1-dodecyloxy-1-phenyl-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one 
• 872216-63-2 1-hydroxy-3-oxo-1-phenyl-5-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)-1,2,4,5-tetrahydro-3H-pyrrolo[3,4-c]pyridine 
• 872216-65-4 4-benzoyl-3-carboxamido-1-(2',3',5'-tri-O-acetyl-β-D-ribofuranosyl)-1,4-dihydropyridine 

Relevant articles and documents

Studies on the 4-benzoylpyridine-3-carboxamide entity as a fragment model of the Isoniazid-NAD adduct

An ortho-metallatkm-electrophilic substitution sequence was employed as a key step to build the 4-benzoylpyridine framework. It was found that 4-benzoylpyridine-3-carboxamide and an N-pyridyl alkylated derivative both exist in a unique cyclized hemiamidal

The first chemical synthesis of the core structure of the benzoylhydrazine-NAD adduct, a competitive inhibitor of the Mycobacterium tuberculosis enoyl reductase

An isoniazid-NAD adduct has been recently proposed as the ultimate metabolite responsible for the antituberculous activity of isoniazid (INH). Its structure results from binding of the isonicotinoyl radical at C4 position of the nicotinamide ring of NAD w